Search results for "symptoms"

showing 10 items of 713 documents

Evaluation of the MGDRx eyebag treatment in young and older subjects with dry eye symptoms

2021

Summary Objectives This study aims to evaluate the relationship between application of the MGDRx thermal eyebag and dry eye signs and symptoms in young and older subjects and to compare the results between the two groups. Methods Thirty young, healthily volunteers between 18 and 31 years of age (23.95 ± 3.94 years) and thirty older subjects between 61 and 90 years of age (77.97 ± 8.11 years) participated in this study. Ocular surface parameters were assessed using the Oculus Keratograph 5 M, following the guidelines of the Tear Film and Ocular Surface Dry Eye Workshop II Diagnostic Methodology report. Only subjects with a positive score on at least one questionnaire and an initial Non-Invas…

Adultmedicine.medical_specialtySigns and symptomsYoung AdultSubjective improvementSurveys and QuestionnairesInternal medicinemedicineHumansTelangiectasiaVolunteerMassagebusiness.industryEyelidsMeibomian GlandsLipidseye diseasesTreatment periodOphthalmologymedicine.anatomical_structureTearsMixed-design analysis of varianceDry Eye Syndromessense organsEyelidmedicine.symptombusinessJournal Français d'Ophtalmologie
researchProduct

Major gender difference in association of FTO gene variant among severely obese children with obesity and obesity related phenotypes.

2008

Recent studies have shown that SNPs in the FTO gene predispose to childhood and adult obesity. In this study, we examined the association between variants in FTO and KIAA1005, a gene that maps closely to FTO, and obesity, as well as obesity related traits among 450 well characterised severely obese children and 512 normal weight controls. FTO showed significant association with several obesity related traits while SNPs in KIAA1005 did not. When stratified by gender, the FTO variant rs9939609 showed association with obesity and BMI among girls (P = 0.006 and 0.004, respectively) but not among boys. Gender differences were also found in the associations of the FTO rs9939609 with obesity relat…

Adultmedicine.medical_specialtyendocrine system diseasesAdolescentmedicine.medical_treatmentBiophysicsAlpha-Ketoglutarate-Dependent Dioxygenase FTOSingle-nucleotide polymorphismBiochemistryFTO genePolymorphism Single NucleotideRisk AssessmentBody Mass IndexInsulin resistanceSex FactorsRisk FactorsInternal medicineDiabetes mellitusmedicinePrevalenceSNPHumansGenetic Predisposition to DiseaseObesitySex DistributionChildMolecular BiologySwedenbusiness.industryInsulinnutritional and metabolic diseasesGenetic VariationProteinspathological conditions signs and symptomsCell Biologymedicine.diseaseObesityEndocrinologyPhenotypeInsulin ResistancebusinessBody mass indexBiochemical and biophysical research communications
researchProduct

Pharmacological interventions for somatoform disorders in adults

2014

BACKGROUND: Somatoform disorders are characterised by chronic, medically unexplained physical symptoms (MUPS). Although different medications are part of treatment routines for people with somatoform disorders in clinics and private practices, there exists no systematic review or meta-analysis on the efficacy and tolerability of these medications. We aimed to synthesise to improve optimal treatment decisions.OBJECTIVES: To assess the effects of pharmacological interventions for somatoform disorders (specifically somatisation disorder, undifferentiated somatoform disorder, somatoform autonomic dysfunction, and pain disorder) in adults.SEARCH METHODS: We searched the Cochrane Depression, Anxi…

Adultmedicine.medical_specialtylow-quality evidencemedicine.medical_treatmentPsychiatry and PsychologyAntidepressive Agents TricyclicCochrane LibraryPlaceboInternal medicineMedicine and Health SciencesmedicineHumansPharmacology (medical)somatoform disorderSomatoform DisordersAntipsychoticPsychiatryinterventionRandomized Controlled Trials as TopicPain disorderMedically unexplained physical symptomsbusiness.industrytrialsMiddle Agedmedicine.diseaseClinical trialPsychological Phenomena and ProcessesTolerabilityMeta-analysisAntidepressive Agents Second-GenerationbusinessSelective Serotonin Reuptake InhibitorsAntipsychotic AgentsCochrane Database of Systematic Reviews
researchProduct

Depression and Serum Content of Serotonin in Adult Patients with Atopic Dermatitis

2020

Atopic dermatitis (AD) is a chronic skin disease with the etiology not yet conclusively established. Recent reports demonstrate the role of serotonin (5-hydroxytryptamine; 5-HT) in the pathogenesis of AD. The aim of this study was to investigate the relationship between the serum content of serotonin and depression in adult patients suffering from severe AD. There were 31 patients of the median age of 41 years enrolled into the study, who suffered from AD since childhood, and a control group that consisted of 14 healthy subjects. AD was diagnosed on the basis of Hanifin and Rajka criteria. The severity of skin lesions was assessed with the SCORing Atopic Dermatitis (SCORAD) index and that o…

Affective symptoms; Atopic dermatitis; Depression; Serotonin; Skin lesions
researchProduct

The Effects of COVID-19 lockdown on neuropsychiatric symptoms in patients with dementia or mild cognitive impairment: A systematic review and meta-an…

2022

The COVID-19 pandemic may have a disproportionate impact on people with dementia/mild cognitive impairment (MCI) due to isolation and loss of services. The aim of this systematic review was to investigate the effects of the COVID-19 lockdown on neuropsychiatric symptoms (NPS) in people living with dementia/MCI. Two authors searched major electronic databases from inception to June 2021 for observational studies investigating COVID-19 and NPS in people with dementia/MCI. Summary estimates of mean differences in NPS scores pre- versus post-COVID-19 were calculated using a random-effects model, weighting cases using inverse variance. Study quality and risk of bias were assessed by the Newcastl…

Aged 80 and overMalemild cognitive impairment neuropsychiatric symptomsCognitive Dysfunction/diagnosisDementia/psychologyCOVID-19Neuropsychological TestsPsychiatry and Mental healthmental disordersCommunicable Disease ControlCOVID-19 dementia mild cognitive impairment neuropsychiatric symptomsHumansCognitive DysfunctionDementiaFemaleGeriatrics and GerontologyGerontologyPandemicsCOVID-19/epidemiologydementiaAgedPsychogeriatrics : the official journal of the Japanese Psychogeriatric Society
researchProduct

Effect of COVID-19 quarantine on cognitive, functional and neuropsychiatric symptoms in patients with mild cognitive impairment and dementia.

2022

Abstract Background During the last two years, COVID-19 affected older people with dementia or mild cognitive impairment (MCI), but conflicting and sparse results are still present. The objective of this study was to investigate the frequency and type of changes in functional, cognitive and behavioral and psychological symptoms of dementia (BPSD), and caregiver’s stress during the period of quarantine in 2020 in patients affected by dementia/MCI living in Palermo, Sicily. Methods Outpatients affected by MCI/dementia were evaluated before and after COVID-19 quarantine. Functional status was investigated using basic and instrumental activities of daily living (ADL); cognitive performance with…

AgingMild cognitive impairmentCOVID-19Neuropsychiatric symptomsCognitionmental disordersActivities of Daily LivingQuarantineHumansCognitive DysfunctionDementiaFemaleGeriatrics and GerontologyAgedAging clinical and experimental research
researchProduct

Caring for People With Dementia Under COVID-19 Restrictions: A Pilot Study on Family Caregivers

2021

IntroductionThe present pilot study examined to what extent the COVID-19 lockdown affected the behavioral and psychological symptoms of dementia (BPSD) in people with dementia and worsened their family caregivers’ distress. The associations between changes in the BPSD of relatives with dementia (RwD) and in their caregivers’ distress, and sense of social and emotional loneliness, and resilience were also investigated.Materials and MethodsThirty-five caregivers of RwD attending formal healthcare services before the COVID-19 lockdown volunteered for the study, and were interviewed by phone during the lockdown. Caregivers completed the NeuroPsychiatric Inventory (NPI) to assess their care reci…

Agingdementia family caregivers caregivers’ distress behavioral and psychological symptoms of dementia (BPSD) loneliness resilience COVID-19 lockdownCoronavirus disease 2019 (COVID-19)Cognitive Neurosciencemedia_common.quotation_subjectNeurosciences. Biological psychiatry. Neuropsychiatrycaregivers’ distress03 medical and health sciences0302 clinical medicineHealth caremedicinelonelinessDementiaresiliencemedia_common030214 geriatricsbusiness.industryFamily caregiversCaring for people with dementiaLonelinessBrief Research Reportmedicine.diseaseDistressCOVID-19 lockdownPsychological resiliencemedicine.symptomfamily caregiversbusinessPsychologybehavioral and psychological symptoms of dementia (BPSD)030217 neurology & neurosurgeryNeuroscienceClinical psychologydementiaRC321-571Frontiers in Aging Neuroscience
researchProduct

Roxindole, a dopamine autoreceptor agonist, in the treatment of positive and negative schizophrenic symptoms

1994

Twenty schizophrenic inpatients with either predominantly positive or predominantly negative symptoms were treated with the dopamine autoreceptor agonist roxindole in prospective open clinical trials. There was no antipsychotic effect in the subgroup with positive symptoms, whereas the subgroup with negative symptoms, especially those with the residual type of schizophrenia, showed a moderate but significant 20% reduction in total scores on the Scale for the Assessment of Negative Symptoms.

Agonistmedicine.medical_specialtyPsychosismedicine.drug_classDopamine AgentsGastroenterologyReceptors Dopaminechemistry.chemical_compoundRoxindoleInternal medicinemental disordersSchizophrenic PsychologymedicineHumansProspective StudiesScale for the Assessment of Negative SymptomsPsychiatric Status Rating ScalesSchizophrenia ParanoidDose-Response Relationship Drugbusiness.industrymedicine.diseaseHospitalizationPsychiatry and Mental healthTreatment OutcomeEndocrinologychemistrySchizophreniaDopamine receptorSchizophreniaAutoreceptorSchizophrenic PsychologybusinessAmerican Journal of Psychiatry
researchProduct

Alterations in the Emotional Regulation Process in Gambling Addiction: The Role of Anger and Alexithymia

2017

This study aims at the assessment of alexithymia and anger levels in 100 treatment-seeking pathological gamblers compared with controls, who were matched for age, gender and education. Furthermore a positive correlation between alexithymia, anger and severity of gambling disorder and a relationship between gambling behaviour and anger after controlling for alexithymia, are investigated. Finally the role that gender plays in anger in pathological gamblers was also evaluated. Psychological assessment includes the South Oaks Gambling Screen, State-Trait Anger Expression Inventory-2 and the twenty-item Toronto Alexithymia Scale. Statistical analysis of the results shows a higher level of anger …

AlexithymiaAdultMalemedicine.medical_specialtyPsychology (all)Personality InventorySociology and Political Sciencemedia_common.quotation_subjectEmotionsBehavioural addictionAngerAngerGambling disorderbehavioral disciplines and activities03 medical and health sciencesToronto Alexithymia Scale0302 clinical medicineAlexithymiaSettore M-PSI/08 - Psicologia Clinicamental disordersmedicineHumansPsychological testingAffective SymptomsPsychiatryPathologicalGeneral Psychologymedia_commonEmotionPathological gamblingmedicine.diagnostic_testAffective SymptomAddictionEmotional regulationmedicine.disease030227 psychiatryBehavior AddictiveDisordered GamblingGamblingbehavior and behavior mechanismsGambling disorderFemalePsychology030217 neurology & neurosurgerypsychological phenomena and processesHuman
researchProduct

Asthma, allergies and respiratory symptoms in different activity groups of swimmers exercising in swimming halls

2021

Abstract Background Respiratory symptoms are common in competitive swimmers. However, among these and in swimmers at other activity levels the swimming distance, the total spent time in swimming halls and their medical background varies. Our objectives were, first, to assess their medical histories and the associations with respiratory symptoms among swimmers in different activity groups and then second, to study the pulmonary function findings and related medications in competitive swimmers who exercise in swimming hall environments the most. Methods First, 1118 participants consisting of 133 competitive-, 734 fitness- and 251 occasional swimmers answered questionnaires concerning their me…

AllergySports medicineAllergyCHILDRENallergiaPulmonary function testingRESPONSIVENESS0302 clinical medicineastmaOrthopedics and Sports MedicineRespiratory symptomsRespiratory systemswimmingSwimming hallsmedicine.diagnostic_testRehabilitationpulmonary functionrespiratory symptomsuimahallitLUNG-FUNCTIONhengityselinten tauditHEALTHRC1200-1245Spirometrymedicine.medical_specialtyPulmonary functionPhysical Therapy Sports Therapy and RehabilitationSpirometry testing03 medical and health scienceshengityselimetBENEFITSmedicinekeuhkosairaudetEXPOSUREkeuhkotSwimmingAsthmabusiness.industryINDUCED BRONCHOCONSTRICTIONResearchuimarit030229 sport sciencesAirway obstructionasthmahengitystietmedicine.diseaseallergyAsthmalääkkeetPOOL ATTENDANCE030228 respiratory systemswimming halls3121 General medicine internal medicine and other clinical medicineuintiSports medicinePhysical therapylääkehoitobusinessBMC Sports Science, Medicine and Rehabilitation
researchProduct